malignant neoplasm originating from melanocytes
World’s first cancer vaccine passes major test: The world’s first-ever cancer vaccine has slashed the risk of tumour recurrence by a staggering 42 per cent in ...
news.com.au/lifestyle/health/worlds-first-cancer-vaccine-passes-major-test-as-tumour-recurrence-slashed-by-42-per-cent/news-story/713db3fc5f8ef490095e4eb8c86ef7cb
Cancer vaccine aims to reduce the risk of melanoma by 42 percent: A personalized mRNA vaccine, in combination with immunotherapy, significantly reduces the risk ...
telepolis.de/article/Krebsimpfstoff-soll-Risiko-bei-Schwarzem-Hautkrebs-um-42-Prozent-reduzieren-11500211.html
Yorkshire Live Oct 15
'Beautiful' woman who used sunbeds to compete for best tan dies after skin cancer diagnosis
examinerlive.co.uk/news/uk-world-news/beautiful-woman-who-used-sunbeds-34767006
CNBC Oct 23
Merck CEO on melanoma vaccine results: The prescribing community will find results quite meaningful
cnbc.com/video/2026/10/23/merck-ceo-on-melanoma-vaccine-results-the-prescribing-community-will-find-results-quite-meaningful.html
🧬 CAR-T cells: From blood cancer to solid tumors? CAR-T cells have significantly advanced the treatment of leukemias and lymphomas ... Show more
Our Chelsea, 30, died after competing with friends for the best tan as teens – her new law will save lives
thesun.co.uk/health/40627975/woman-dies-tan-contest-skin-cancer/
Fewer biopsies, faster diagnoses: How AI is changing skin cancer detection in the UK
tz.de/wissen/hautkrebs-ki-erkennt-melanome-mit-99-prozent-genauigkeit-zr-94527354.html
Paid articlePaywall What's next for personalized mRNA cancer vaccines?: Personalized mRNA cancer vaccines are expanding beyond melanoma into tougher solid tumors.
seekingalpha.com/news/4650205-whats-next-for-personalized-mrna-cancer-vaccines
Scientists find surprise link between grey hair and cancer: Research reveals that grey hairs are a small example of a cell choosing to bow out rather than risk ...
independent.co.uk/life-style/health-and-families/grey-hair-cancer-cells-study-b2859432.html
STAT Oct 05
Paid articlePaywall Divergent trial results on cancer vaccines have the field grappling with hard questions
statnews.com/2026/10/05/cancer-vaccines-mrna-clinical-trials/
.jpeg?trim=0,129,0,171&crop=&width=1200&auto=webp&quality=75)
Watch: Perton man with stage 2B melanoma trains for shark cage dive fundraiser: He will head to Australia this time next year
expressandstar.com/watch-this/watch-perton-man-with-stage-2b-melanoma-trains-for-shark-cage-dive-fundraiser-9221828
Moderna Down In Premarket After Citi Calls Valuation ‘Unjustifiable’: Moderna stock has rallied more than 200% since August, following positive Phase 3 trial ...
go.forbes.com/9Klbgh
Barron's Sep 29
Paid articlePaywall Iovance Stock Surges as Strong Melanoma Drug Demand Drives Growth: Iovance Biotherapeutics raised its fiscal-year guidance on Tuesday.
barrons.com/articles/iovance-therapeutics-melanoma-drugs-revenue-165bd5c6
Thanks to immunotherapy, the survival rate for skin cancer has improved significantly. Currently, 50 percent of people with stage IV melanoma survive for ten ... Show more
Upper Austrian News | OÖN
Upper Austrian News | OÖN
A melanoma vaccine was hailed as a breakthrough. Which cancers are next?: Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other ...
washingtonpost.com/health/2026/09/19/melanoma-vaccine-was-hailed-breakthrough-which-cancers-are-next/
The Observer Sep 26
How social media helped make sunbeds dangerous again: Melanoma is now one of the most common cancers in people aged 15 to 34, and attributed to a growing trend ...
observer.co.uk/news/national/article/how-social-media-helped-make-sunbeds-dangerous-again
💚 Real Racing Club and Cantabria Labs join forces to promote melanoma prevention 🔎 The incidence of skin cancer has skyrocketed by 40% in the last four years ... Show more
Real Racing Club and Cantabria Labs join forces to promote melanoma prevention
Real Racing Club and Cantabria Labs join forces to promote melanoma prevention
Greens MP Tim Read dies after cancer battle: Victoria Greens have announced Brunswick MP Tim Read died aged 66 following a 10 month battle with melanoma.
news.com.au/national/victoria/politics/victorian-greens-mp-tim-read-has-died-after-cancer-battle/news-story/b8349436f5784889e1531f72ec6a6559
London Tough Mudder in memory of Isle of Wight's Zoe Panayi: The team took on the London South Tough Mudder, raising funds for Mountbatten Hospice on the Isle of ...
countypress.co.uk/news/26567526.london-tough-mudder-memory-isle-wights-zoe-panayi/
people.com Sep 17
🔗: people.com/teddi-mellencamp-shares-reminder-get-your-skin-checked-immunotherapy-day-stage-4-cancer-12124807? Teddi Mellencamp showed off the scars on her back from repeated surgeries for melanoma in a grim reminder to “get your skin checked ... Show more
people.com/teddi-mellencamp-shares-reminder-get-your-skin-checked-immunotherapy-day-stage-4-cancer-12124807?taid=6aab81ebdce6860001d9d465
people.com/teddi-mellencamp-shares-reminder-get-your-skin-checked-immunotherapy-day-stage-4-cancer-12124807?taid=6aab81ebdce6860001d9d465
A new personalised cancer vaccine, which is being trialled by patients in Scotland, could change the way doctors treat the disease in the future ... Show more
Isle of Wight clinic sees jump in skin cancer referrals: Malcolm White, general manager at The Lighthouse Clinic in Newport, said the surge is “way beyond” the ...
countypress.co.uk/news/26554915.isle-wight-clinic-sees-jump-skin-cancer-referrals/
A new personalised cancer vaccine, which is being trialled by patients in Scotland, could change the way doctors treat the disease in the future ... Show more
Cleveland Clinic Aug 20
Amelanotic melanoma is a rare skin cancer that doesn’t look dark like typical melanomas. It may appear pink or skin-colored and grow quickly ... Show more
40 to run London Tough Mudder in memory of Zoe Panayi: The group, one of the largest teams ever assembled in her memory, will take on more than 20 obstacles ...
countypress.co.uk/news/26522671.40-run-london-tough-mudder-memory-zoe-panayi/
Cleveland Clinic Aug 18
The ABCDEs of melanoma are an easy way to remember what to look for in a suspicious mole. It stands for asymmetry, border, color, diameter and evolving ... Show more
OpinionAI is getting good at detecting skin cancer — if you have light skin : If an AI model is never taught what melanoma looks like on dark skin, it simply won’t know ...
houstonchronicle.com/opinion/outlook/article/ai-skin-cancer-dark-skin-22428066.php
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at ...
edition.cnn.com/2026/08/21/health/mrna-cancer-vaccines-wave
Revolutionary breakthrough in melanoma: New cancer therapy dramatically increases survival chances
tz.de/wissen/revolutionaerer-durchbruch-bei-melanom-neue-krebs-therapie-erhoeht-ueberlebschancen-enorm-zr-94471600.html
Melanoma in India: why the messaging needs to change to catch it early : Learn why early detection and tailored messaging are vital for melanoma care in India ...
thehindu.com/sci-tech/health/melanoma-in-india-why-the-messaging-needs-to-change-to-catch-it-early/article71446585.ece
TDs raise concerns over future of skin cancer surveillance services at CUH: Earlier this year, the issue over the future of melanoma treatment ...
irishexaminer.com/news/munster/arid-41909887.html
Cleveland Clinic Aug 19
Nodular melanoma is a type of skin cancer. It’s a firm, raised, discolored growth on your skin that may look like a blood blister ... Show more
My Doctor Removed My Entire Nose To Save My Life. Here's How My Greatest Nightmare Became A Dream Come True.
huffpost.com/entry/melanoma-cancer-nose-surgery-removal-life-changing_n_6aa1a0c5e4b0186919a8016c
HPV, Hepatitis B, Melanoma: Which cancer vaccines exist - | and why a universal vaccine is unrealistic
tz.de/welt/krebsimpfstoffe-welche-es-gibt-und-was-sie-wirklich-leisten-zr-94458415.html
🌞 Pasty Man, a newly launched New York City sunscreen brand, is making its case for sun protection with an unusual piece of evidence: the rather youthful ... Show more
Pasty Man uses a 90-year-old butt to make its case for sunscreen
Pasty Man uses a 90-year-old butt to make its case for sunscreen
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope
reut.rs/4gm7A4f
Philstar Life Aug 20
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope
philstarlife.com/news-and-views/991859-moderna-merck-vaccine-cuts-recurrence-and-spread-of-melanoma-raising-new-treatment-hope
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at ...
edition.cnn.com/2026/08/21/health/mrna-cancer-vaccines-wave
What Witney Carson Wants Women to Know About Skin Cancer: Plus, a dermatologist shares how often to get a skin check, the difference between mineral and chemical ...
womenshealthmag.com/health/a71351681/witney-carson-melanoma-interview/
I’ve got terminal cancer after complaining about ‘flickering’ office lights – my warning to others
thesun.co.uk/health/40156829/terminal-eye-cancer-flickering-office-lights-warning/
Cancer therapy: Moderna reports positive results in study of skin cancer vaccine: Moderna has published positive study data on a novel melanoma vaccine ...
zeit.de/gesundheit/2026-08/mrna-krebsimpfstoff-moderna-merck-intismeran-keytruda-melanom
A new mRNA cancer vaccine hit its goal in melanoma patients, giving a healthcare giant a fresh growth story.
Read more: 135-year-old healthcare giant surges on cancer vaccine breakthrough | MRK
Mark Orwig, 73, grew up in an era before parents slathered their children with sunscreen and enjoyed a career playing and coaching tennis ... Show more
Moderna and Merck said that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial ... Show more
Where can melanoma develop? When is an examination necessary? What progress is being made in research? Prof. Christoffer Gebhardt provides information ... Show more
STAT Aug 19
Paid articlePaywall Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial: The personalized mRNA cancer vaccine, added to Merck's Keytruda ...
statnews.com/2026/08/19/mrna-cancer-vaccine-trial-melanoma-merck-moderna/
Skin cancer breakthrough after experimental mRNA drug found to prevent disease returning
independent.co.uk/news/health/mrna-drug-skin-cancer-trial-merck-moderna-vaccine-b3035615.html
What Witney Carson Wants Women to Know About Skin Cancer: Plus, a dermatologist shares how often to get a skin check, the difference between mineral and chemical ...
womenshealthmag.com/health/a71351681/witney-carson-melanoma-interview/
‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial: The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines ...
straitstimes.com/world/united-states/breakthrough-mrna-cancer-drug-curbs-melanoma-in-large-trial
Malaga leads trial of Spain's first personalised melanoma vaccine: Hospital Regional accounts for a third of the patients and the sponsors, Moderna and MSD ...
surinenglish.com/lifestyle/health/malaga-leading-trial-20260821112658-nt.html
An experimental vaccine from Moderna has prevented the return and spread of cancer in high-risk melanoma patients.
The company’s shares surged more than 175% ... Show more
Moderna shares more than doubled, adding $44 billion in market value in a day — Here’s why
financialexpress.com/market/global-markets/moderna-stock-surges-177-in-one-day-heres-what-triggered-the-44-billion-market-cap-jump/4321804/
Stocks skyrocket after cancer vaccine trial: Pharmaceutical giant Moderna’s share price exploded by more than 170 per cent overnight as investors reacted to its ...
news.com.au/lifestyle/health/promising-cancer-vaccine-breakthrough/news-story/0c2155d457d7fb33e729d0858dd44a2a
wb.md Aug 06
A mole (nevus) is a benign growth of melanocytes, cells that gives skin its color. Although very few moles become cancer, abnormal or atypical moles can ... Show more
Is That a Mole or Something Else?
Is That a Mole or Something Else?
Moderna-Merck Breakthrough Cancer Vaccine Shows Promise In Clinical Trial For Melanoma Treatment
How does Moderna’s new mRNA cancer vaccine work? : Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK
independent.co.uk/news/uk/home-news/moderna-cancer-vaccine-mrna-stock-b3036266.html
Pharmaceutical giants Moderna and Merck said Wednesday that their experimental cancer treatment showed signs of success in a study with high-risk melanoma ... Show more
Merck and Moderna surge on cancer vaccine breakthrough : A new mRNA cancer vaccine hit its goal in melanoma patients, giving a healthcare giant a fresh growth ...
star-telegram.com/news/business/article316949142.html
CBS Mornings : A personalized mRNA cancer vaccine, plus a drug called Keytruda, reduced the return and spread of melanoma in high-risk patients, a medical trial found ... Show more
Do Tattoos Cause Cancer? A New Study Challenges What We Think We Know.: I’m covered in tattoos. At least 40 at this point, although I’ve lost any idea as to what ...
vice.com/en/article/do-tattoos-cause-cancer-a-new-study-challenges-what-we-think-we-know/
Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands
mirror.co.uk/news/health/skin-cancer-vaccine-breakthrough-jab-37572075
Saudi Gazette Aug 20
Landmark moment for cancer treatment as drug curbs melanoma in large trial: US drugmakers Merck and Moderna on Wednesday announced encouraging results from a ...
saudigazette.com.sa/article/663893/life/landmark-moment-for-cancer-treatment-as-drug-curbs-melanoma-in-large-trial
How does the Moderna cancer vaccine that sent stocks surging 177% work?: Moderna stocks almost tripled on Wednesday (August 19) after the pharma giant completed ...
firstpost.com/explainers/moderna-cancer-vaccine-stocks-surge-intismeran-autogene-trial-14039442.html
Key FactsModerna Shares Surge 177% After Cancer Vaccine Study
Aug 20, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: diepresse.com
Summary created with AI assistance · Source: diepresse.com
- Moderna shares rose 177% on Wednesday, August 19, 2026; short sellers lost five billion dollars that day.
- The final Phase 3 trial of Intismeran succeeded; combined with Keytruda, it significantly reduced recurrences after melanoma surgery.
- For each patient, Intismeran is produced as an individualized mRNA vaccine from a tumor tissue sample.
- A universal cancer vaccine is not in sight; Moderna is also testing the technology against lung and bladder cancer.
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy ...
rappler.com/science/life-health/moderna-merck-breakthrough-cancer-vaccines/
yicaiglobal.com Aug 20
Moderna's shares [NASDAQ: MRNA] surged 177% to an over two-year high yesterday, after the drugmaker and its partner Merck unveiled breakthrough trial ... Show more
Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients who had ... Show more
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread: Moderna’s mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in ...
aljazeera.com/news/2026/8/19/moderna-merck-unveil-mrna-based-cancer-vaccine-that-cuts-spread
Moderna shares soar 150% after personalised cancer vaccine breakthrough: The vaccine is currently being studied on melanoma, which is responsible for about 1 per ...
indianexpress.com/article/world/moderna-merck-personalised-mrna-melanoma-cancer-vaccine-10840762/
Moderna's stock is soaring on the success of its cancer vaccine trial's success.
Moderna and Merck's personalized vaccine helps cut the ... Show more
finance.yahoo.com
finance.yahoo.com
Moderna Soars 90%, Merck Jumps On Cancer Vaccine Trial Win: A combo treatment significantly extended the time before melanoma returned.
investors.com/news/technology/moderna-stock-skyrockets-over-60-merck-jumpslate-stage-cancer-vaccine-trial-win/
Paid articlePaywall Moderna shares jump nearly 100% on skin cancer trial success: Late-stage trial results show melanoma treatment cut recurrence and spread when paired with Merck’s ...
thetimes.com/business/companies-markets/article/moderna-shares-soar-mrna-cancer-vaccine-bk7p5lw53
Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial: The mRNA-based vaccine combined with Keytruda reduced melanoma ... Show more
Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial
Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial
BioNTech Competitor: Moderna Shares Soar After Melanoma Study: U.S. biotech company Moderna reports positive results in a study on the treatment of melanoma ...
manager-magazin.de/unternehmen/moderna-aktien-mit-kursrallye-melanom-studie-zeigt-erste-erfolge-bei-krebstherapie-auch-biontech-profitiert-a-d206673a-4bb5-4aa6-9ce3-6a926ffb5f00